ImmunoMind
PrivateLast Round
Accelerator
Sep 15, 2020
Total Funding Raised
$105,000
Company Overview
ImmunoMind is a biotechnology company that provides an open-source ecosystem for designing personalized immunotherapies and vaccines using systems immunology.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoMind Comparables
Compare ImmunoMind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ozette | 84% | |
| ENPICOM | 78% | |
| Scailyte AG | 77% | |
ImmunoMind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 15, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 1370% MoM.
- Sep 15, 2020
$105K raised led by SkyDeck.
ImmunoMind Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunoMind's valuation, stock price, and market status.